Arkolith/Insider Trading/GMTX/Form 4/A

Lubner David Charles

DirectorGemini Therapeutics, Inc. /DE (GMTX) · full profile →Form 4/A · filed Mar 9, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
0 non-derivative · 1 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 12, 2021Grant(A)18K—$018K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001209191-22-017671) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML